Cargando…
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients
The emergence of treatment resistant sub-clones is a key feature of relapse in multiple myeloma. Therapeutic attempts to extend remission and prevent relapse include maximizing response and the use of maintenance therapy. We used whole exome sequencing to study the genetics of paired samples taken a...
Autores principales: | Jones, John R., Weinhold, Niels, Ashby, Cody, Walker, Brian A., Wardell, Chris, Pawlyn, Charlotte, Rasche, Leo, Melchor, Lorenzo, Cairns, David A., Gregory, Walter M., Johnson, David, Begum, Dil B., Ellis, Sidra, Sherborne, Amy L., Cook, Gordon, Kaiser, Martin F., Drayson, Mark T., Owen, Roger G., Jackson, Graham H., Davies, Faith E., Greaves, Mel, Morgan, Gareth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601103/ https://www.ncbi.nlm.nih.gov/pubmed/30733268 http://dx.doi.org/10.3324/haematol.2018.202200 |
Ejemplares similares
-
Enhancing cancer clonality analysis with integrative genomics
por: Peterson, Erich A, et al.
Publicado: (2015) -
Clonal expansion in B-CLL: Fungal drivers or self-service?
por: Greaves, Mel
Publicado: (2013) -
Single cell analysis of clonal architecture in acute myeloid leukaemia
por: Potter, Nicola, et al.
Publicado: (2018) -
Single-cell mutational profiling and clonal phylogeny in cancer
por: Potter, Nicola E., et al.
Publicado: (2013) -
Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial
por: Jones, John R., et al.
Publicado: (2023)